language_icon
EN
HI

Indoco Remedies Share price

INDOCO

215.26

9.64 (-4.29%)
NSE
BSE
Last updated on 18 May, 2026 | 15:41 IST
Today's High

222.89

Today's Low

214.20

52 Week Low

162.19

52 Week High

349.80

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Indoco Remedies Chart

Indoco Remedies Share Key Metrics

Volume
54771.00
Market Cap
1986.93 CR
LTQ@LTP
1@215.26
ATP
216.56
Var Margin
21.71 %
Circuit Range
179.92-269.88
Delivery %
55.92 %
Value
1.19 CR
ASM/GSM
No
Market Lot
1

Summary

Indoco Remedies share price is ₹215.26 as of 18 May, 2026. The stock Indoco Remedies intraday movement has stayed between ₹214.20 and ₹222.89, while on a 52-week basis,Indoco Remedies price 52 week high is ₹349.80 & its 52 week low is ₹162.19.
In terms of trading activity, Indoco Remedies has recorded a volume of 54771 shares, The Indoco Remedies has a market cap of ₹92303605 CR. The stock’s Average Traded Price (ATP) stands at ₹216.56, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹215.26.
Indoco Remedies operates within a circuit range of ₹179.92 – ₹269.88, with a Value of ₹1.19 CR. The Delivery Percentage for the day is 55.92%. Additionally, Indoco Remedies currently falls under the No framework, and trades with a market lot size of 1.

Indoco Remedies Fundamentals

View More
P/E Ratio

0

P/B Ratio

2.21

Div. Yield

0.09

Sector P/E

71.32

Sector P/B

3.45

Sec. Div. Yield

0.56

Indoco Remedies Resistance and Support

Pivot 226.07

Resistance

First Resistance

228.83

Second Resistance

232.76

Third Resistance

235.52

Support

First Support

222.14

Second Support

219.38

Third Support

215.45

Indoco Remedies Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

58.8%

Mutual Fund

18.21%

Insurance

0.13%

Foreign Institutional Investors

1.25%

Domestic Institutional Investors

0.57%

Retail

21.06%

Others

-0.02%

Total Promoters
MAR '24
58.72%
JUN '24
58.75%
SEP '24
58.75%
DEC '24
58.8%

Indoco Remedies Corporate Actions

DateAgenda
2026-05-07Audited Results & Final Dividend
2026-02-03Quarterly Results
2025-11-06Quarterly Results
2025-07-24Quarterly Results
2025-05-22Audited Results & Final Dividend
2025-01-21Quarterly Results

Indoco Remedies News

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

Indoco Remedies completed the slump sale of its Ophthalmic Division to Sunways (India) Private Limited on May 18, 2026. This strategic transfer encompasses various international territories, including India.
May 18 2026 20:05:00

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Indoco Remedies' Baddi Unit-I manufacturing facility has successfully received EU GMP certification from the Malta Medicines Authority. This certification confirms compliance with Good Manufacturing Practice requirements for its solid oral dosage form production.
May 14 2026 11:05:00

Indoco Remedies Limited

Indoco Remedies announced the slump sale of its Ophthalmic Division to Sunways (India) Private Limited for a cash consideration of Rs. 110 crore. This strategic move aims to enable the company to focus on its core therapeutic areas.
May 01 2026 14:05:00

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

Indoco Remedies has divested its Ophthalmic Division to Sunways (India) Private Limited for a consideration of Rs. 110 crore. This strategic move aims to enable the company to focus on its core therapeutic areas.
Apr 30 2026 19:04:00

Indoco Remedies Limited

Indoco Remedies divested its ophthalmic business division to Sunways (India) Private Limited for Rs. 110 crore. This strategic move allows Indoco to focus on its core therapeutic areas.
Apr 30 2026 19:04:00

Indoco Remedies Limited

Indoco Remedies Limited approved the transfer of its ophthalmic business in India and Africa to Sunways (India) Private Limited. This strategic move aims to sharpen Indoco's focus on core therapeutic areas with higher potential.
Apr 30 2026 19:04:00

Indoco Remedies Limited

Indoco Remedies Limited's Board approved the slump sale of its Ophthalmic Division, covering specific territories, to Sunways (India) Private Limited for Rs. 110 crores. This strategic divestment allows the company to focus on core therapeutic areas.
Apr 30 2026 18:04:00

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

Indoco Remedies' Board approved the divestment of its Ophthalmic Division in India and other territories to Sunways (India) Private Limited via a slump sale for Rs. 110 crore. This strategic move aims to sharpen the company's focus on its core therapeutic segments.
Apr 30 2026 18:04:00
Read More

About Indoco Remedies

NSE : 11677  
BSE : 532612  
ISIN : INE873D01024  

Our HistoryWe were incorporated on August 23 1947 as Indoco Remedies Limited asa public company under the Indian Companies Act VII of 1913 and wasissued a Certificate for commencement of business on October 8 1947.In 1945 a Goan entrepreneur Mr. Govind Ramnath Kare who was in thebusiness of wholesale and retail trade of pharmaceuticals started afirm which he named Indo Continental Trading Company. The principalbusiness of this firm was to import pharmaceutical formulations fromEurope and distribute them in Western India. However in 1947 afterIndia became independent the new Government in its bid to encourageindigenous manufacturing of medicines banned import of severalformulations. Mr. G.R. Kare decided to venture into manufacturing ofpharmaceuticals. Accordingly a new Company was founded with the intentto manufacture and sell pharmaceutical formulations. Thus IndoContinental Trading Company became Indoco Remedies Limited. The Companywas incorporated with S.S. Ugrankar Mr. B K Naik Mr. A S Kamat Mr. KS Nayak Mr. V G Gaitonde Mr. N M Kamat Mr. R S Kamat and Mr. G RKare as the shareholders and S.S. Ugrankar Mr S K Ananda Rao Dr. M GCamotin Mr. E D Pai Raiturkar Mr. B K Naik Mr. VRN Rasaikar Mr. G RKare Mr. RS Kamat and Mr. V G Gaitonde as directors. Thereafter in1963 our present Chairman and Managing Director Mr Suresh G.Karetook over the management of the Company. The registered office of theCompany was located at 457 Dwarkadas Mansions Sandhurst Road BombayThis was changed to 101 Neelam Worii Seaface Road Abdul Gaffar KhanRoad Bombay 400 018 vide a board resolution dated August 15 1968which was subsequently changed to 18A Mahal Estate Mahakali CavesRoad Andheri (East) Mumbai - 400 093 vide a board resolution datedJune 1 1985 and an extra-ordinary general meeting dated May 24 1985.This was changed to the current location at 166 C.S.T. Road Santacruz(East) Mumbai - 400 098 India vide a board resolution dated December26 1999

Read More

Indoco Remedies Management

NamePosition
Suresh G KareChairman
Aditi PanandikarManaging Director
View More

Indoco Remedies FAQs

The Buying Price of Indoco Remedies share is 215.26 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Indoco Remedies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Indoco Remedies, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Indoco Remedies shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Indoco Remedies shares is 2.21. Useful to assess the stock's value relative to its book value.

To assess Indoco Remedies’s valuation compare Sector P/E, P/B which are 71.32 & 3.45 with sector averages, along with growth rates and financial metrics.

The Market Cap of Indoco Remedies is 1986.93 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Indoco Remedies share price is 349.80 & 162.19. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Indoco Remedies belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost